Dr. Sokolova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3485 S. Bond Avenue Portland
Portland, OR 97239Phone+1 503-494-7999- Is this information wrong?
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2017 - 2021
- Nassau University Medical CenterResidency, Internal Medicine, 2014 - 2017
- Rostov State Medical UniversityClass of 2013
Certifications & Licensure
- WA State Medical License 2017 - 2026
- OR State Medical License 2021 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.Joseph J Park, Alec Chu, Jinju Li, Alicia Ali, Rana R McKay, Clara Hwang, Matthew K Labriola, Albert Jang, Deepak Kilari, George Mo, Deepak Ravindranathan, Laura S Gra...> ;JCO Precision Oncology. 2024 Apr 1
- PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.Channing J Paller, Pedro C Barata, Justin Lorentz, Leonard J Appleman, Andrew J Armstrong, Tiffani A DeMarco, Robert Dreicer, Jo Ann B Elrod, Mark Fleming, Christopher...> ;The Prostate. 2024 Feb 1
- Balancing Treatment Benefits of Androgen-Receptor Signal Inhibitors and Quality of Life in Patients With Prostate Cancer.Alexandra O Sokolova, Julie N Graff> ;JAMA Oncology. 2023 Jul 1
- Join now to see all
Press Mentions
- Certain Toxic Effects Higher with Newer Prostate Cancer TherapiesMay 26th, 2023
- Immunotherapy and PARP Inhibitors in Biochemical Recurrent Prostate Cancer - Alexandra SokolovaAugust 7th, 2022
- Treating Biochemical Recurrent Prostate Cancer: ARV 110 Trial and the Fortis Study - Alexandra SokolovaAugust 7th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: